Verrica Pharmaceuticals Inc

-0.10 (-1.06%)
Earnings Announcements

Verrica Pharmaceuticals Reports Qtrly Net Loss Per Share Of $0.42

Published: 11/09/2020 13:10 GMT
Verrica Pharmaceuticals Inc. (VRCA) - Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results.
Believes Cash, Cash Equivalents Will Be Sufficient to Support Planned Operations at Least Through Q4 of 2021.
Qtrly Net Loss per Share $0.42.
Q3 Earnings per Share View $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.